Amyloid β-peptide (25-35) (human)
Cat. No. 1429
Biological ActivityFragment of human amyloid β-peptide, functionally required for the neurotrophic and neurotoxic effects associated with Alzheimer's disease.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Schenk et al (1995) Therapeutic approaches related to amyloid-β peptide and Alzheimer's Disease J.Med.Chem. 38 4141. PMID: 7473539.
Rush et al (1992) Intracerebral β-amyloid(25-35) produces tissue damage: is it neurotoxic? Neurobiol.Aging 13 591. PMID: 1281289.
Yankner et al (1990) Neurotrophic and neurotoxic effects of amyoid β protein: reversal by tachykinin neuropeptides. Science 250 279. PMID: 2218531.
If you know of a relevant reference for Amyloid β-peptide (25-35) (human) please let us know.
Citations are publications that use Tocris products. Selected citations for Amyloid β-peptide (25-35) (human) include:
Ostrovskaya et al (2014) Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation. J.Biomed.Sci. 21 74. PMID: 25096780.
Do you know of a great paper that uses Amyloid β-peptide (25-35) (human) from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Amyloid b-peptide (25-35) (human), supplier, Human, amyloid, β-protein, beta-protein, fragment, functionally, neurotoxicity, β-Amyloid, beta-Amyloid, b-amyloid, Precursor, Protein, APP, Secretase, Peptides, Amyloid, β-peptide, beta-peptide, (25-35), (human), amyloidbeta, amyloidb, Tocris Bioscience, Amyloid β Peptide products